Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Spironolactone might lower the chance of getting rosacea.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Skin tags in obese individuals may indicate higher cardiovascular risk.

High testosterone increases heart disease risk in women with PCOS.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Men with Kennedy disease have less chance of hair loss.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.